UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Private Payers and Cancer Care: Revisiting the Land of Opportunity

JCO oncology practice, 2024-03, Vol.20 (3), p.318

2024

Volltextzugriff (PDF)

The community oncologist: part of the solution

Journal of the National Comprehensive Cancer Network, 2011-04, Vol.9 (4), p.345

Kolodziej, Michael A

2011

Volltextzugriff (PDF)

Does evidence-based medicine really reduce costs?

Oncology (Williston Park, N.Y.), 2011-03, Vol.25 (3), p.214, 218-218

Kolodziej, Michael A

2011

Volltextzugriff (PDF)

Alternative approaches to paying for cancer care

Oncology (Williston Park, N.Y.), 2011-02, Vol.25 (2), p.108, 110, 113-113

Kolodziej, Michael A

2011

Volltextzugriff (PDF)

Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting

The American journal of managed care, 2014-03, Vol.20 (5 Spec No.), p.E4-E4

2014

Volltextzugriff (PDF)

Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting

The American journal of managed care, 2014-02, Vol.20 (2 Spec No.), p.E6-E6

2014

Volltextzugriff (PDF)

Electronic patient-reported outcomes in a cohort of patients with lung cancer treated in the community with shorter versus longer course PD1/PDL1 therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18810-e18810

2023

Volltextzugriff (PDF)

ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and inpatient utilization

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1508-1508

2022

Volltextzugriff (PDF)

Time on treatment is prolonged in patients utilizing an ePRO based digital symptom monitoring platform in the community setting

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1528-1528

2022

Volltextzugriff (PDF)

Successful implementation of an ePRO remote monitoring system in patients receiving chemotherapy in a community oncology practice

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1526-1526

2021

Volltextzugriff (PDF)

Management strategies for WBC growth factor use

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6619-6619

2016

Volltextzugriff (PDF)

Electronic calculation of quality measures in the EMR and dependence on data capture in structured fields: The OCM quality reporting experience

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18278-e18278

2017

Volltextzugriff (PDF)

Patient support call center: Interaction with the oncology clinic

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.84-84

2016

Volltextzugriff (PDF)

Savings impact of a second-to-market oncology pathway

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e17538-e17538

2014

Volltextzugriff (PDF)

Impact of site of service on chemotherapy costs: Influence of geographic location and diagnosis

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6601-6601

2015

Volltextzugriff (PDF)

A disease management pilot program in a Medicare-age population with cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6505-6505

2016

Volltextzugriff (PDF)

Implementation of the IOM 13 point care plan by Oncology Care Model (OCM) practices

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18279-e18279

2017

Volltextzugriff (PDF)

Evaluation of a lung cancer population in an oncology Medicare advantage program

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19117-e19117

2015

Volltextzugriff (PDF)

Telephonic Advance Care Planning (ACP) with Medicare patients with advanced cancer: Interim program results

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17712-e17712

2015

Volltextzugriff (PDF)

Retrospective observational study: Bevacizumab (B) use and outcomes among metastatic colorectal cancer (mCRC) patients (pts) receiving care in the outpatient community in the United States

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.547-547

2012

Volltextzugriff (PDF)

Impact of Disease Progression On Healthcare Cost and Resource Utilization Among Follicular NHL Patients Treated within the US Oncology Network

Blood, 2009-11, Vol.114 (22), p.4543-4543

2009

Volltextzugriff (PDF)

Changes in adjuvant breast cancer chemotherapy regimen selection over time in the community

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6109-6109

2012

Volltextzugriff (PDF)

Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck : a Southwest Oncology Group study

Investigational new drugs, 1998-01, Vol.16 (3), p.271-274

1998

Volltextzugriff (PDF)

Determinants of the intracellular fate of truncated forms of the platelet glycoproteins IIb and IIIa

The Journal of biological chemistry, 1993-02, Vol.268 (5), p.3580-3585

1993

Volltextzugriff (PDF)

Study of the endoproteolytic cleavage of platelet glycoprotein IIb using oligonucleotide-mediated mutagenesis

The Journal of biological chemistry, 1991-12, Vol.266 (34), p.23499-23504

1991

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(138)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(156)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(74)
Humans
(52)
Male
(25)
Animals
(24)
Biological And Medical Sciences
(20)
Oncology
(20)
Female
(15)
Middle Aged
(15)
Technology
(15)
Aged
(13)
Adult
(12)
Medical Sciences
(12)
Chemistry
(10)
Computer Science
(10)
Mice
(10)
Neoplasms - Therapy
(10)
Physical Sciences
(10)
Science & Technology - Other Topics
(10)
Computer Science, Theory & Methods
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Private Payers and Cancer Care: Revisiting the Land of Opportunity

The community oncologist: part of the solution

Does evidence-based medicine really reduce costs?

Alternative approaches to paying for cancer care

Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting

Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting

Electronic patient-reported outcomes in a cohort of patients with lung cancer treated in the community with shorter versus longer course PD1/PDL1 therapy

ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and inpatient utilization

Time on treatment is prolonged in patients utilizing an ePRO based digital symptom monitoring platform in the community setting

Successful implementation of an ePRO remote monitoring system in patients receiving chemotherapy in a community oncology practice

Management strategies for WBC growth factor use

Electronic calculation of quality measures in the EMR and dependence on data capture in structured fields: The OCM quality reporting experience

Patient support call center: Interaction with the oncology clinic

Savings impact of a second-to-market oncology pathway

Impact of site of service on chemotherapy costs: Influence of geographic location and diagnosis

A disease management pilot program in a Medicare-age population with cancer

Implementation of the IOM 13 point care plan by Oncology Care Model (OCM) practices

Evaluation of a lung cancer population in an oncology Medicare advantage program

Telephonic Advance Care Planning (ACP) with Medicare patients with advanced cancer: Interim program results

Retrospective observational study: Bevacizumab (B) use and outcomes among metastatic colorectal cancer (mCRC) patients (pts) receiving care in the outpatient community in the United States

Impact of Disease Progression On Healthcare Cost and Resource Utilization Among Follicular NHL Patients Treated within the US Oncology Network

Changes in adjuvant breast cancer chemotherapy regimen selection over time in the community

Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck : a Southwest Oncology Group study

Determinants of the intracellular fate of truncated forms of the platelet glycoproteins IIb and IIIa

Study of the endoproteolytic cleavage of platelet glycoprotein IIb using oligonucleotide-mediated mutagenesis

Suchergebnisse filtern